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Comments
Here, we report a rare case of a t(8;9)(p12;q33) in a patient with c-ALL. The peripheral blood was infiltrated with CD10+, CD19+, CD34+, HLA-DR+ as well as cytoplasmatic TdT+, CD79a+ and CD22+ lymphoblasts. Additionally, cells showed abnormal coexpression of CD33 and CD13. Chromosome banding analysis revealed a 46,XY,t(8;9)(p12;q33) karyotype, and a FGFR1-CEP110 fusion transcript was detected by reverse transcription-polymerase chain reaction (RT-PCR). Patients with a t(8;9)(p12;q33) that have been published so far showed either a myeloid or biphenotypic malignancy, often presenting a myeloproliferative neoplasia or a myeloproliferative neoplasia in transformation (Chaffanet et al., 1998; Guasch et al., 2000; Sohal et al., 2001; Yamamoto et al., 2006; Mozziconacci et al., 2008; Park et al., 2008) . Contrary to previous reports we did not observe myeloid involvement in our patient. Both the EGIL criteria for biphenotypic acute leukemia as well as the WHO classification for mixed phenotype acute leukaemia are not met here (Bene et al., 1995; Swerdlow et al., 2008) . Thus, this is -to our knowledgethe first description of a patient with a t(8;9)(p12;q33), who presented solely with a lymphoid malignancy.
